Discovery of a small molecule promoting mouse and human osteoblast differentiation via activation of p38 MAPK-beta

Disorders of bone healing and remodeling are indications with an unmet need for effective pharmacological modulators. We used a high throughput screen to identify activators of the bone marker alkaline phosphatase (ALP), and discovered 6,8- di methyl-3-(4- p henyl-1H-imidazol-5-yl) qu inolin-2(1H)- o ne (DIPQUO). DIPQUO markedly promotes osteoblast differentiation, including expression of Runx2, Osterix, and Osteocalcin. Treatment of human mesenchymal stem cells with DIPQUO results in osteogenic differentiation including a significant increase in calcium matrix deposition. DIPQUO stimulates ossification of emerging vertebral primordia in developing zebrafish larvae, and increases caudal fin osteogenic differentiation during adult zebrafish fin regeneration. The stimulatory effect of DIPQUO on osteoblast differentiation and maturation was shown to be dependent on the p38 MAPK pathway. Inhibition of p38 MAPK signaling or specific knockdown of the p38-beta isoform attenuates DIPQUO induction of ALP, suggesting that DIPQUO mediates osteogenesis through activation of p38-beta, and is a promising lead candidate for development of bone therapeutics. This compound is a promising candidate to develop a new bone healing drug.

[1]  Eri Shibata,et al.  Osteoblast Production by Reserved Progenitor Cells in Zebrafish Bone Regeneration and Maintenance. , 2017, Developmental cell.

[2]  D. Lorich,et al.  Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance , 2017, Proceedings of the National Academy of Sciences.

[3]  Nghia T. Vo,et al.  Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties , 2017, Scientific Reports.

[4]  A. LaCroix,et al.  Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative , 2016, Menopause.

[5]  K. Stensløkken,et al.  Osteoblast Differentiation at a Glance , 2016, Medical science monitor basic research.

[6]  A. Grauer,et al.  Romosozumab Treatment in Postmenopausal Women with Osteoporosis. , 2016, The New England journal of medicine.

[7]  K. Kaneko,et al.  Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications , 2015, Therapeutic advances in chronic disease.

[8]  J. Caverzasio,et al.  Focus on the p38 MAPK signaling pathway in bone development and maintenance. , 2015, BoneKEy reports.

[9]  M. Greenblatt,et al.  p38α MAPK Is Required for Tooth Morphogenesis and Enamel Secretion* , 2014, The Journal of Biological Chemistry.

[10]  M. Kyba,et al.  High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity , 2014, Skeletal Muscle.

[11]  T. He,et al.  BMP signaling in mesenchymal stem cell differentiation and bone formation. , 2013, Journal of biomedical science and engineering.

[12]  Arpita Tiwari,et al.  Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Spine Fusion , 2013, Annals of Internal Medicine.

[13]  T. He,et al.  Wnt signaling in bone formation and its therapeutic potential for bone diseases , 2013, Therapeutic advances in musculoskeletal disease.

[14]  C. Kimmel,et al.  Hedgehog-dependent proliferation drives modular growth during morphogenesis of a dermal bone , 2012, Development.

[15]  M. Montano,et al.  A novel library screen identifies immunosuppressors that promote osteoblast differentiation. , 2012, Bone.

[16]  A. Bandyopadhyay,et al.  BRITER: A BMP Responsive Osteoblast Reporter Cell Line , 2012, PloS one.

[17]  Jamie L. Marshall,et al.  High Throughput Screening for Compounds That Alter Muscle Cell Glycosylation Identifies New Role for N-Glycans in Regulating Sarcolemmal Protein Abundance and Laminin Binding , 2012, The Journal of Biological Chemistry.

[18]  K. Hankenson,et al.  Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation , 2011, Journal of cellular biochemistry.

[19]  S. Diamond,et al.  Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening , 2011, PloS one.

[20]  Bradley K Weiner,et al.  A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.

[21]  Michael D. Schneider,et al.  The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. , 2010, The Journal of clinical investigation.

[22]  A. Masuda,et al.  JNK Activity Is Essential for Atf4 Expression and Late‐Stage Osteoblast Differentiation , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  N. Plaster,et al.  Restriction of retinoic acid activity by Cyp26b1 is required for proper timing and patterning of osteogenesis during zebrafish development , 2008, Development.

[24]  A. Kudo,et al.  The teleost intervertebral region acts as a growth center of the centrum: In vivo visualization of osteoblasts and their progenitors in transgenic fish , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  Stuart B Goodman,et al.  The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. , 2007, Tissue engineering.

[26]  R. Rizzoli,et al.  Evidences for a role of p38 MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells. , 2007, Bone.

[27]  A. McMahon,et al.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors , 2006, Development.

[28]  Robert Nadon,et al.  Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.

[29]  Qisheng Zhang,et al.  Dedifferentiation of lineage-committed cells by a small molecule. , 2004, Journal of the American Chemical Society.

[30]  M. Fussenegger,et al.  Dual-regulated expression of C/EBP-alpha and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts. , 2004, Nucleic acids research.

[31]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[32]  L. Zon,et al.  Cdc42Hs, but Not Rac1, Inhibits Serum-stimulated Cell Cycle Progression at G1/S through a Mechanism Requiring p38/RK* , 1997, The Journal of Biological Chemistry.

[33]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[34]  R. Davis,et al.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.

[35]  N. Takahashi,et al.  Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage , 2002 .